已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis

医学 心房颤动 内科学 超重 华法林 体质指数 荟萃分析 优势比 冲程(发动机) 随机对照试验 心脏病学 机械工程 工程类
作者
Aaqib H. Malik,Srikanth Yandrapalli,Suchith Shetty,Wilbert S. Aronow,Diwakar Jain,William H. Frishman,Howard A. Cooper,Julio A. Panza
出处
期刊:Europace [Oxford University Press]
卷期号:22 (3): 361-367 被引量:25
标识
DOI:10.1093/europace/euz361
摘要

This study sought to determine the impact of weight and body mass index (BMI) on the safety and efficacy of direct-acting oral anticoagulants (DOACs) compared with warfarin in patients with non-valvular atrial fibrillation.A systematic literature search was employed in PubMed, Embase, and Cochrane clinical trials with no language or date restrictions. Randomized trials or their substudies were assessed for relevant outcome data for efficacy that included stroke or systemic embolization (SSE), and safety including major bleeding and all-cause mortality. Binary outcome data and odds ratios from the relevant articles were used to calculate the pooled relative risk. For SSE, the data from the four Phase III trials showed that DOACs are better or similarly effective with low BMI 0.73 (0.56-0.97), normal BMI 0.72 (0.58-0.91), overweight 0.87 (0.76-0.99), and obese 0.87 (0.76-1.00). The risk of major bleeding was also better or similar with DOACs in all BMI subgroups with low BMI 0.62 (0.37-1.05), normal BMI 0.72 (0.58-0.90), overweight 0.83 (0.71-0.96), and obese 0.91 (0.81-1.03). There was no impact on mortality in all the subgroups. In a meta-regression analysis, the effect size advantage of DOACs compared with warfarin in terms of safety and efficacy gradually attenuated with increasing weight.Our findings suggest that a weight-based dosage adjustment may be necessary to achieve optimal benefits of DOACs for thromboembolic prevention in these patients with non-valvular atrial fibrillation. Further dedicated trials are needed to confirm these findings. PROSPERO 2019 CRD42019140693. Available from: https://www.crd.york.ac.uk/prospero/display_record.php? ID=CRD42019140693.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
3秒前
8秒前
nito发布了新的文献求助10
8秒前
顺利的飞荷完成签到,获得积分0
9秒前
Poker应助515采纳,获得10
9秒前
小猪佩奇完成签到,获得积分10
11秒前
14秒前
18秒前
闪闪小小完成签到 ,获得积分10
20秒前
20秒前
Freeasy完成签到 ,获得积分10
22秒前
23秒前
听雨完成签到 ,获得积分10
23秒前
SUE完成签到,获得积分10
28秒前
28秒前
29秒前
传奇3应助vivid采纳,获得10
33秒前
山奈发布了新的文献求助10
34秒前
wyp发布了新的文献求助10
36秒前
ljx123完成签到,获得积分10
36秒前
FashionBoy应助Xangel采纳,获得10
36秒前
图雄争霸完成签到 ,获得积分10
36秒前
38秒前
39秒前
wanci应助聂白晴采纳,获得30
41秒前
Sienna发布了新的文献求助10
43秒前
星辰大海应助极地东风采纳,获得10
44秒前
小萌完成签到 ,获得积分10
46秒前
希望天下0贩的0应助wpx采纳,获得10
47秒前
48秒前
阿北完成签到,获得积分10
48秒前
52秒前
vivid发布了新的文献求助10
52秒前
Sienna完成签到,获得积分10
55秒前
hyhyhyhy发布了新的文献求助10
57秒前
CipherSage应助wyp采纳,获得10
1分钟前
wkjfh举报怕黑的亦瑶求助涉嫌违规
1分钟前
yahonyoyoyo发布了新的文献求助10
1分钟前
slycmd完成签到,获得积分10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989811
求助须知:如何正确求助?哪些是违规求助? 3531927
关于积分的说明 11255560
捐赠科研通 3270706
什么是DOI,文献DOI怎么找? 1805035
邀请新用户注册赠送积分活动 882181
科研通“疑难数据库(出版商)”最低求助积分说明 809190